
Umamaheswari Ramachandran
Examiner (ID: 1992, Phone: (571)272-9926 , Office: P/1627 )
| Most Active Art Unit | 1627 |
| Art Unit(s) | 1627, 1617 |
| Total Applications | 1598 |
| Issued Applications | 702 |
| Pending Applications | 154 |
| Abandoned Applications | 762 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10676831
[patent_doc_number] => 20160022976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'METHOD AND COMPOSITION FOR HYPERTHERMALLY TREATING CELLS'
[patent_app_type] => utility
[patent_app_number] => 14/869051
[patent_app_country] => US
[patent_app_date] => 2015-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 45818
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14869051
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/869051 | Method and composition for hyperthermally treating cells | Sep 28, 2015 | Issued |
Array
(
[id] => 10656197
[patent_doc_number] => 20160002341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'Stabilized Formulations Containing Anti-Interleukin-6 Receptor (IL-6R) Antibodies'
[patent_app_type] => utility
[patent_app_number] => 14/861565
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13442
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861565
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/861565 | Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies | Sep 21, 2015 | Issued |
Array
(
[id] => 14977917
[patent_doc_number] => 10442859
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-15
[patent_title] => Therapeutic use of anti-CS1 antibodies
[patent_app_type] => utility
[patent_app_number] => 14/860906
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 40028
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14860906
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/860906 | Therapeutic use of anti-CS1 antibodies | Sep 21, 2015 | Issued |
Array
(
[id] => 10712713
[patent_doc_number] => 20160058860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 14/849212
[patent_app_country] => US
[patent_app_date] => 2015-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 35990
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14849212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/849212 | VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT | Sep 8, 2015 | Abandoned |
Array
(
[id] => 10481740
[patent_doc_number] => 20150366756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 14/846184
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 52767
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14846184
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/846184 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | Sep 3, 2015 | Issued |
Array
(
[id] => 14849555
[patent_doc_number] => 10413481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-17
[patent_title] => Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
[patent_app_type] => utility
[patent_app_number] => 14/846080
[patent_app_country] => US
[patent_app_date] => 2015-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 27283
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14846080
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/846080 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | Sep 3, 2015 | Issued |
Array
(
[id] => 10712718
[patent_doc_number] => 20160058863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-03
[patent_title] => 'LOW VISCOSITY CONCENTRATED PROTEIN DISPERSIONS'
[patent_app_type] => utility
[patent_app_number] => 14/843897
[patent_app_country] => US
[patent_app_date] => 2015-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 93899
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14843897
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/843897 | LOW VISCOSITY CONCENTRATED PROTEIN DISPERSIONS | Sep 1, 2015 | Abandoned |
Array
(
[id] => 10705521
[patent_doc_number] => 20160051668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'METHODS FOR IMPROVING IMMUNOLOGICAL RESPONSE IN VACCINATED ANIMALS'
[patent_app_type] => utility
[patent_app_number] => 14/831602
[patent_app_country] => US
[patent_app_date] => 2015-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 19112
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14831602
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/831602 | Methods for improving immunological response in vaccinated animals | Aug 19, 2015 | Issued |
Array
(
[id] => 10670885
[patent_doc_number] => 20160017030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 14/814051
[patent_app_country] => US
[patent_app_date] => 2015-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 45307
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814051
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/814051 | HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY FORMULATION | Jul 29, 2015 | Abandoned |
Array
(
[id] => 13035419
[patent_doc_number] => 10039822
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
[patent_app_type] => utility
[patent_app_number] => 14/802260
[patent_app_country] => US
[patent_app_date] => 2015-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 11
[patent_no_of_words] => 35527
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14802260
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/802260 | Method for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses | Jul 16, 2015 | Issued |
Array
(
[id] => 10656182
[patent_doc_number] => 20160002327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'METHODS OF PURIFYING ANTI-INTERLEUKIN-13 ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 14/798685
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13068
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14798685
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/798685 | Anti-interleukin-13 antibody compositions | Jul 13, 2015 | Issued |
Array
(
[id] => 13854067
[patent_doc_number] => 10188740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-29
[patent_title] => Modified Fc molecules
[patent_app_type] => utility
[patent_app_number] => 14/796502
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 37308
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14796502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/796502 | Modified Fc molecules | Jul 9, 2015 | Issued |
Array
(
[id] => 10444572
[patent_doc_number] => 20150329586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'Refolding Proteins Using a Chemically Controlled Redox State'
[patent_app_type] => utility
[patent_app_number] => 14/793590
[patent_app_country] => US
[patent_app_date] => 2015-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10027
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14793590
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/793590 | Refolding Proteins Using a Chemically Controlled Redox State | Jul 6, 2015 | Abandoned |
Array
(
[id] => 13079415
[patent_doc_number] => 10059765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds
[patent_app_type] => utility
[patent_app_number] => 14/789548
[patent_app_country] => US
[patent_app_date] => 2015-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 16696
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789548
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/789548 | Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds | Jun 30, 2015 | Issued |
Array
(
[id] => 10492846
[patent_doc_number] => 20150377869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-31
[patent_title] => 'PURIFICATION OF NANOPARTICLE-ANTIBODY CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/749022
[patent_app_country] => US
[patent_app_date] => 2015-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3059
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14749022
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/749022 | PURIFICATION OF NANOPARTICLE-ANTIBODY CONJUGATES | Jun 23, 2015 | Abandoned |
Array
(
[id] => 10388072
[patent_doc_number] => 20150273079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING'
[patent_app_type] => utility
[patent_app_number] => 14/737180
[patent_app_country] => US
[patent_app_date] => 2015-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11369
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14737180
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/737180 | IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING | Jun 10, 2015 | Abandoned |
Array
(
[id] => 11727901
[patent_doc_number] => 20170189345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-06
[patent_title] => 'NANOENCAPSULATION OF ANTIGEN-BINDING MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 15/315293
[patent_app_country] => US
[patent_app_date] => 2015-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7403
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15315293
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/315293 | NANOENCAPSULATION OF ANTIGEN-BINDING MOLECULES | May 28, 2015 | Abandoned |
Array
(
[id] => 10600265
[patent_doc_number] => 09320813
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-26
[patent_title] => 'Method and composition for hyperthermally treating cells'
[patent_app_type] => utility
[patent_app_number] => 14/724577
[patent_app_country] => US
[patent_app_date] => 2015-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 38619
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724577
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/724577 | Method and composition for hyperthermally treating cells | May 27, 2015 | Issued |
Array
(
[id] => 10374105
[patent_doc_number] => 20150259111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'METHOD OF STORING A VACCINE CONTAINING AN ALUMINUM ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 14/720515
[patent_app_country] => US
[patent_app_date] => 2015-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4611
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14720515
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/720515 | Method of storing a vaccine containing an aluminum adjuvant | May 21, 2015 | Issued |
Array
(
[id] => 10324331
[patent_doc_number] => 20150209335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'METHODS AND SMALL MOLECULE THERAPEUTICS COMPRISING FUSED ELPS'
[patent_app_type] => utility
[patent_app_number] => 14/683033
[patent_app_country] => US
[patent_app_date] => 2015-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13028
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14683033
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/683033 | METHODS AND SMALL MOLECULE THERAPEUTICS COMPRISING FUSED ELPS | Apr 8, 2015 | Abandoned |